In 2024, multiple drugs received complete response letters (CRLs), sometimes unrelated to the safety and efficacy of the drug, but patients with schizophrenia gained the first new treatment with a new ...

A review of the FDA’s drug approvals of 2024 shows that small companies loomed large—both in the sheer number of nods gained and the significance of the new drugs and biologics that these firms are ...

In this article, I review five key developments from the past year and offer five items to watch for in 2025. This past year featured key developments in the prescription drug policy area, including ...

The National Institute for Occupational Safety and Health (NIOSH) has published the 2024 update to its List of Hazardous Drugs in Healthcare Settings, marking the first revision since 2016. The ...

Median annual list price for new drugs over $370,000 in 2024 72% of new drugs in 2024 for orphan diseases Drugmakers emphasize value, offer savings programs amid rising list prices May 22 (Reuters) - ...